Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
21.71
+0.51 (2.41%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Stevanato Group Revenue
Stevanato Group had revenue of 302.00M EUR in the quarter ending June 30, 2026, with 7.84% growth. This brings the company's revenue in the last twelve months to 1.23B, up 7.00% year-over-year. In the year 2025, Stevanato Group had annual revenue of 1.19B with 7.45% growth.
Revenue (ttm)
1.23B EUR
Revenue Growth
+7.00%
P/S Ratio
4.24
Revenue / Employee
203,868 EUR
Employees
6,010
Market Cap
5.93B USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.19B | 82.25M | 7.45% |
| Dec 31, 2024 | 1.10B | 18.68M | 1.72% |
| Dec 31, 2023 | 1.09B | 101.67M | 10.34% |
| Dec 31, 2022 | 983.68M | 139.76M | 16.56% |
| Dec 31, 2021 | 843.92M | 181.88M | 27.47% |
| Dec 31, 2020 | 662.04M | 125.50M | 23.39% |
| Dec 31, 2019 | 536.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Avantor | 6.56B |
| Bausch + Lomb | 5.32B |
| AptarGroup | 3.93B |
| MiniMed Group | 3.10B |
| Envista Holdings | 2.86B |
| Teleflex | 2.25B |
| ICU Medical | 2.16B |
| Merit Medical Systems | 1.58B |
STVN News
- 15 days ago - Stevanato Group Earnings Call Transcript: Q2 2026 - Transcripts
- 15 days ago - Stevanato Group Earnings release: Q2 2026 - Filings
- 15 days ago - Stevanato Group Slides: Q2 2026 - Filings
- 15 days ago - Stevanato Group reports Q2 EPS EUR0.08 vs. EUR0.11 last year - TheFly
- 15 days ago - Stevanato Group narrows 2026 adjusted EPS view to EUR0.60-EUR0.62 - TheFly
- 15 days ago - Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026 - Business Wire
- 20 days ago - Stevanato Group’s Alina pen injector platform authorized in Europe - TheFly
- 20 days ago - Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries - Business Wire